13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 70 holding rows worth $2,795,946,341.
- Accession
- 0001104659-24-023671
- Filer
- CIK 1425738
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 70 entries on the cover page, a total value of $2,795,946,341 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,795,946,341 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 16,423,922 | $486,969,287 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,733,189 | $215,019,427 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 14,828,321 | $210,413,875 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 6,402,505 | $120,367,094 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 1,857,706 | $115,493,582 | dollars as filed | |
| AUGMEDIX INC | 05105P107 | COM | 16,380,327 | $95,824,913 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 4,801,540 | $77,448,840 | dollars as filed | |
| SPY | 78462F103 | SHS | 142,500 | $67,731,675 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 3,760,690 | $67,504,386 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,444,365 | $61,818,822 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 5,790,230 | $60,160,490 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 1,137,068 | $58,831,898 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,659,264 | $54,486,441 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 1,100,466 | $49,443,937 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 13,169,057 | $49,252,273 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,696,648 | $48,836,295 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 1,823,956 | $46,437,920 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 3,879,415 | $41,509,741 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 977,072 | $41,164,043 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 693,200 | $40,073,892 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,619,914 | $40,069,987 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 993,803 | $39,414,227 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,429,783 | $38,918,693 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 8,031,094 | $33,730,595 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 3,256,519 | $33,607,276 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 935,863 | $33,298,006 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 3,865,258 | $32,584,125 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,374,189 | $31,194,090 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 265,500 | $29,223,585 | dollars as filed | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 835,537 | $27,597,787 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,109,476 | $25,906,265 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 15,328,317 | $25,445,006 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 5,503,190 | $24,984,483 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 2,971,542 | $24,693,514 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,718,669 | $23,958,246 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 95,242 | $23,957,173 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,969,402 | $21,998,220 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 86,782 | $20,515,265 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 1,283,735 | $19,371,561 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 946,897 | $18,350,864 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 54,258 | $18,304,479 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 66,100 | $17,891,948 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,914,022 | $17,134,449 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 53,141 | $15,913,604 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,148,748 | $15,685,860 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 2,625,506 | $13,810,162 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 50,082 | $13,722,468 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 5,872,605 | $11,980,114 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,324,350 | $11,733,741 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 23,079 | $10,883,133 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 3,670,447 | $10,020,320 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 2,000,000 | $10,000,000 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 366,776 | $9,114,384 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,402,443 | $5,954,275 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,440,725 | $5,676,457 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644207 | COMMON | 990,412 | $5,288,800 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 9,106,446 | $4,669,786 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,031,009 | $4,576,824 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,074,372 | $3,277,508 | dollars as filed | |
| MEDAVAIL HOLDINGS INC COM NEW | 58406B202 | NEW | 692,082 | $3,052,082 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,046,587 | $2,459,479 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,608,089 | $1,429,591 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 1,907,969 | $1,297,037 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 370,839 | $938,223 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 1,474,026 | $923,919 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 1,063,769 | $861,653 | dollars as filed | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 161,005 | $600,549 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 715,607 | $567,476 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 207,203 | $511,791 | dollars as filed | |
| ATRECA INC | 04965G109 | COM | 442,653 | $58,430 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-023671 | this filing | 2024-02-14 | acceptance time not in the bulk data set |